Frequent occurrence of CD19-negative relapse after CD19 CAR T and consolidation therapy in 14 TP53-mutated r/r B-ALL children

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Leukemia 2020-12, Vol.34 (12), p.3382-3387
Hauptverfasser:	Pan, Jing, Tan, Yue, Deng, Biping, Tong, Chunrong, Hua, Lin, Ling, Zhuojun, Song, Weiliang, Xu, Jinlong, Duan, Jiajia, Wang, Zelin, Guo, Huilin, Yu, Xinjian, Chang, Alex H., Zheng, Qinlong, Feng, Xiaoming
Format:	Artikel
Sprache:	eng
Schlagworte:	13/31 38/91 45/22 45/23 45/43 45/77 45/90 45/91 692/308/575 692/699/67/1059/2325 Acute lymphocytic leukemia Antigens, CD19 - genetics Cancer Research Care and treatment CD19 antigen Cellular proteins Cellular therapy Child Consolidation Chemotherapy - methods Critical Care Medicine Development and progression Genetic aspects Health aspects Hematology Humans Intensive Internal Medicine Letter Leukemia, Biphenotypic, Acute - drug therapy Leukemia, Biphenotypic, Acute - genetics Medicine Medicine & Public Health Methods Mutation - genetics Oncology p53 Protein Patient outcomes Receptors, Antigen, T-Cell - genetics Receptors, Chimeric Antigen - genetics Recurrence Tumor Suppressor Protein p53 - genetics
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!